New IBD treatment offers hope for 70% of patients
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- IBD Patients may soon have more effective treatment options, addressing the current low success rate of existing drugs.
- Drugmakers stand to gain substantially from developing and marketing new IBD treatments, tapping into a market with significant unmet needs.
- The New Approach targets the root cause of IBD symptoms—chronic inflammation in the digestive tract—offering a more precise and potentially more effective way to manage the disease.
Why it matters: This breakthrough could dramatically improve the quality of life for millions suffering from debilitating IBD symptoms, while also creating a lucrative market for pharmaceutical innovation.
